Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alerts86803 – Qualitative or Semiquantitative Immunoassays; Hepatitis C antibody
CPT-86000-FEBRILE-AGGLUTININS-SEROLOGIC-TESTCPT 86000: Serologic Test for Febrile Agglutinins
CPT-86001-ALLERGEN-SPECIFIC-IGG-LABORATORY-TESTCPT 86001: Allergen-specific Immunoglobulin G (IgG) Test
CPT-86003-ALLERGEN-SPECIFIC-IGE-ASSAY-TECHNICALCPT 86003: Allergen-Specific IgE Assay, Technical Component
CPT-86005-MULTI-ALLERGEN-IGE-SCREENING-QUALITATIVECPT 86005: Multi-Allergen IgE Screening, Qualitative
CPT-86008-ALLERGEN-COMPONENT-SPECIFIC-IGE-ASSAYCPT 86008: Allergen Component-Specific IgE Assay
CPT-86015-ANTI-ACTIN-SMOOTH-MUSCLE-ANTIBODY-ASMACPT 86015: Anti‑Actin (Smooth Muscle) Antibody (ASMA) Test
CPT-86021-LEUKOCYTE-ANTIBODY-IDENTIFICATION-LAB-TECHNICALCPT 86021: Leukocyte Antibody Identification, Technical Laboratory Service
CPT-86022-PLATELET-ANTIBODY-IDENTIFICATION-TECHNICAL-TESTCPT 86022: Platelet Antibody Identification, Technical Component
CPT-86023-PLATELET-ASSOCIATED-IMMUNOGLOBULIN-DETECTIONCPT 86023: Platelet-Associated Immunoglobulin Detection
Showing 1–10 of 200
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.